{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:19:18Z","timestamp":1793945958365,"version":"4.8.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ajo.2026.07.026","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:03:38Z","timestamp":1784588618000},"page":"282-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Predictive Factors for Progression in Sickle Cell Retinopathy: Longitudinal Evaluation of a United States Cohort"],"prefix":"10.1016","volume":"291","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7957-4928","authenticated-orcid":false,"given":"ANSHUMAN","family":"AGRAWAL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-4881","authenticated-orcid":false,"given":"NUR","family":"CARDAKLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WENQING","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"UDUAK E.","family":"OBOT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0744-5139","authenticated-orcid":false,"given":"ANUPAM K.","family":"GARG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADRIENNE W.","family":"SCOTT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajo.2026.07.026_bib0001","doi-asserted-by":"crossref","first-page":"248","DOI":"10.15585\/mmwr.mm7312a1","article-title":"Birth prevalence of sickle cell disease and county-level social vulnerability: sickle cell data collection program, 11 states, 2016-2020","volume":"73","author":"Kayle","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.ajo.2026.07.026_bib0002","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the global burden of disease study 2021","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"issue":"3","key":"10.1016\/j.ajo.2026.07.026_bib0003","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9394(71)90429-6","article-title":"Classification and pathogenesis of proliferative sickle retinopathy","volume":"71","author":"Goldberg","year":"1971","journal-title":"Am J Ophthalmol"},{"issue":"Pt 3","key":"10.1016\/j.ajo.2026.07.026_bib0004","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/eye.1988.62","article-title":"Patterns of visual loss in untreated sickle cell retinopathy","volume":"2","author":"Moriarty","year":"1988","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.026_bib0005","first-page":"26","article-title":"Funduscopic alterations in SS and SC hemoglobinopathies. Study of a Brazilian population","volume":"197","author":"Bonanomi","year":"1988","journal-title":"Ophthalmologica"},{"issue":"11","key":"10.1016\/j.ajo.2026.07.026_bib0006","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ophtha.2005.05.026","article-title":"Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study","volume":"112","author":"Downes","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.07.026_bib0007","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajo.2018.09.025","article-title":"Clinical and ophthalmic factors associated with the severity of sickle cell retinopathy","volume":"197","author":"Duan","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.07.026_bib0008","series-title":"Sickle Retinopathy","author":"Fekrat","year":"1998"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.026_bib0009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.65.1.29","article-title":"Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease","volume":"65","author":"Hayes","year":"1981","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.07.026_bib0010","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/bjo.65.10.712","article-title":"Haematological factors associated with proliferative retinopathy in sickle cell-haemoglobin C disease","volume":"65","author":"Hayes","year":"1981","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.026_bib0011","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40942-022-00419-8","article-title":"Risk factors associated with sickle cell retinopathy: findings from the cooperative study of sickle cell disease","volume":"8","author":"Nawaiseh","year":"2022","journal-title":"Int J Retina Vitreous"},{"issue":"7","key":"10.1016\/j.ajo.2026.07.026_bib0012","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.oret.2020.11.017","article-title":"Variable practice patterns for management of sickle cell retinopathy","volume":"5","author":"Mishra","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"13","key":"10.1016\/j.ajo.2026.07.026_bib0013","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/bloodadvances.2022009147","article-title":"Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study","volume":"7","author":"Brandsen","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.026_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228399","article-title":"Sickle cell disease: a distinction of two most frequent genotypes (HbSS and HbSC)","volume":"15","author":"da Guarda","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.026_bib0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/asheducation-2016.1.625","article-title":"Sickle cell disease: when and how to transfuse","volume":"2016","author":"Howard","year":"2016","journal-title":"Hematology"},{"key":"10.1016\/j.ajo.2026.07.026_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211046559","article-title":"Hematopoietic stem cell transplant for sickle cell disease: patient selection and timing based on sickle cell-related multiple chronic conditions","volume":"30","author":"Jang","year":"2021","journal-title":"Cell Transplant"},{"issue":"4","key":"10.1016\/j.ajo.2026.07.026_bib0017","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/IAE.0b013e3181f049ec","article-title":"Detection and monitoring of sickle cell retinopathy using ultra wide-field color photography and fluorescein angiography","volume":"31","author":"Cho","year":"2011","journal-title":"Retina"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2026.07.026_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40942-019-0177-8","article-title":"Wide-field imaging of sickle retinopathy","volume":"5","author":"Linz","year":"2019","journal-title":"Int J Retina Vitreous"},{"issue":"12","key":"10.1016\/j.ajo.2026.07.026_bib0019","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1097\/IAE.0000000000004247","article-title":"Macular neurodegenerative and vascular changes on optical coherence tomographic angiography in sickle cell disease are not related to its ocular and systemic complications","volume":"44","author":"Brandsen","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2026.07.026_bib0020","first-page":"481","article-title":"The ocular manifestations of sickle-cell disease: a prevalence and natural history study","volume":"90","author":"Clarkson","year":"1992","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.026_bib0021","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12020-018-1697-y","article-title":"The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis","volume":"62","author":"Cai","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.026_bib0022","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bjo.2005.073643","article-title":"Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation","volume":"90","author":"Khan","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"18","key":"10.1016\/j.ajo.2026.07.026_bib0023","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1182\/blood-2010-01-265819","article-title":"Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease","volume":"115","author":"Cohen","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ajo.2026.07.026_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13111131","article-title":"Secondhand smoke is an important modifiable risk factor in sickle cell disease: a review of the current literature and areas for future research","volume":"13","author":"Sadreameli","year":"2016","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.026_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/CH-2012-1622","article-title":"Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia","volume":"55","author":"Lemaire","year":"2013","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.ajo.2026.07.026_bib0026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajo.2021.10.030","article-title":"Nonmydriatic ultra-widefield fundus photography in a hematology clinic shows utility for screening of sickle cell retinopathy","volume":"236","author":"Ahmed","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.026_bib0027","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamaophthalmol.2020.5900","article-title":"Deep learning detection of sea fan neovascularization from ultra-widefield color fundus photographs of patients with sickle cell hemoglobinopathy","volume":"139","author":"Cai","year":"2021","journal-title":"JAMA Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:51:40Z","timestamp":1790772700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426004022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S0002939426004022"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.07.026","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Factors for Progression in Sickle Cell Retinopathy: Longitudinal Evaluation of a United States Cohort","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}